×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Are Sawai Group Holdings Co., Ltd.'s (TSE:4887) Mixed Financials Driving The Negative Sentiment?
Simply Wall Street
Sawai Group Holdings (TSE:4887) has had a rough week with its share price down 4.8%. We, however decided to study the...
2 days ago
Neurolief Announces Strategic Equity Investment by Sawai Group Holdings USA - English
PR Newswire
Comprising highly experienced professionals with a proven track record in neuroscience, neuromodulation technology and the neurotech devices...
4 months ago
Neurolief secures equity investment from Japan's Sawai Group
Medical Device Network
... Sawai Group. The non-invasive, at-home wearable neuromodulation therapy Relivion is designed for treating migraine and depression. January 2, 2024.
4 months ago
Bora Pharmaceuticals acquires Upsher-Smith from Sawai and Sumitomo
outsourcing-pharma.com
Bora Pharmaceuticals Co., Ltd. yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics...
1 month ago
Bora Pharmaceuticals to acquire Upsher-Smith for $210M
Drug Store News
Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing...
3 months ago
Bora Pharmaceutical Makes First U.S. Acquisition to Buy Upsher-Smith for $210 Million
GeneOnline
Bora Pharmaceuticals, Taiwan's leading biotech CDMO company, revealed its plan to acquire U.S.-based Upsher-Smith Laboratories on January...
3 months ago
Bora Pharmaceuticals completes the acquisition of Upsher-Smith
hometownsource.com
Bora Pharmaceuticals Co., Ltd. announced April 1 that it has successfully completed the acquisition of Upsher-Smith Laboratories,...
4 weeks ago
Taiwan's Bora Pharma acquires US-based Upsher-Smith for $210 M to fuel global expansion
BioSpectrum Asia
Marking Bora's inaugural acquisition in the US, signifying a pivotal expansion of Bora's presence in the US market.
3 months ago
Bora to buy Upsher-Smith for $210 million
The Pharma Letter
Taiwan's Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer.
3 months ago
Sawai joins list of drugmakers known for manufacturing misconduct
The Japan Times
The company had been fraudulently using capsules with new, replaced outer shells for post-approval quality testing, in place of ones it...
6 months ago